Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hillel Panitch

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature Clinical Practice. Neurology|February 7, 2007
Do patients with clinically isolated syndrome benefit from treatment with interferon beta1b?Hillel Panitch
Expert Opinion on Pharmacotherapy|June 4, 2011
Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disabilityHillel Panitch, Angela Applebee
Biologics : Targets & Therapy|August 27, 2009
Early stage and long term treatment of multiple sclerosis with interferon-betaAngela Applebee, Hillel Panitch
Journal of Neuroimmunology|November 30, 2010
Combination therapy in multiple sclerosisRon Milo, Hillel Panitch
Journal of the Neurological Sciences|April 17, 2007
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affectAriel Miller, Hillel Panitch
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localizationYang Mao-Draayer, Hillel Panitch
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled studyHillel Panitch, Aaron Miller, Donald Paty, et al.
Neurology|October 9, 2002
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchangeYang Mao-Draayer, Steven Braff, William Pendlebury, et al.
Biochemical and Biophysical Research Communications|July 22, 2009
The effect of interferon-beta on mouse neural progenitor cell survival and differentiationMarek Hirsch, Julia Knight, Mari Tobita, et al.
Journal of Neuroimmunology|March 3, 2007
Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI responseJerome J Graber, David Ford, Min Zhan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Neurology|February 7, 2007
Do patients with clinically isolated syndrome benefit from treatment with interferon beta1b?Hillel Panitch
Expert Opinion on Pharmacotherapy|June 4, 2011
Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disabilityHillel Panitch, Angela Applebee
Biologics : Targets & Therapy|August 27, 2009
Early stage and long term treatment of multiple sclerosis with interferon-betaAngela Applebee, Hillel Panitch
Journal of Neuroimmunology|November 30, 2010
Combination therapy in multiple sclerosisRon Milo, Hillel Panitch
Journal of the Neurological Sciences|April 17, 2007
Therapeutic use of dextromethorphan: key learnings from treatment of pseudobulbar affectAriel Miller, Hillel Panitch
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localizationYang Mao-Draayer, Hillel Panitch
Neurology|November 24, 2004
Interferon beta-1b in secondary progressive MS: results from a 3-year controlled studyHillel Panitch, Aaron Miller, Donald Paty, et al.
Neurology|October 9, 2002
Treatment of steroid-unresponsive tumefactive demyelinating disease with plasma exchangeYang Mao-Draayer, Steven Braff, William Pendlebury, et al.
Biochemical and Biophysical Research Communications|July 22, 2009
The effect of interferon-beta on mouse neural progenitor cell survival and differentiationMarek Hirsch, Julia Knight, Mari Tobita, et al.
Journal of Neuroimmunology|March 3, 2007
Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI responseJerome J Graber, David Ford, Min Zhan, et al.
Pageof 2